Pacifica, CA, United States of America

Seema Kantak

This inventor holds 3 USPTO granted patents and 12 published patent applications and 1 EPO patent. Top assignees: Nektar Therapeutics, Schering Corporation. Active years: 2012-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Seema Kantak. Retrieved from https://idiyas.com/inventor/seema-kantak

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 66.7

 

Average Co-Inventor Count = 4.7

ph-index = 2

Forward Citations = 30(Granted Patents)


Company Filing History:


Years Active: 2012-2020

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Seema Kantak: Innovator in Cancer Treatment

Introduction

Seema Kantak is a notable inventor based in Pacifica, CA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of new therapeutic methods. With a total of 3 patents, his work focuses on enhancing the efficacy of cancer therapies.

Latest Patents

One of Seema Kantak's latest patents involves IL-2Rβ-selective agonists in combination with an anti-CTLA-4 antibody or an anti-PD-1 antibody. This invention relates to a method of administering treatment to patients suffering from cancer. The method comprises two key steps: (a) administering an IL-2Rβ-activating amount of a long-acting, IL-2Rβ-selective agonist, and (b) administering a CTLA-4 pathway-inhibiting amount of an anti-CTLA-4 antibody or a PD-1 pathway-inhibiting amount of an anti-PD-1 antibody. This innovative approach aims to improve patient outcomes in cancer therapy.

Career Highlights

Throughout his career, Seema Kantak has worked with prominent companies in the pharmaceutical industry, including Nektar Therapeutics and Schering Corporation. His experience in these organizations has allowed him to develop and refine his expertise in cancer treatment innovations.

Collaborations

Seema has collaborated with notable professionals in his field, including Murali Krishna Addepalli and Deborah H. Charych. These collaborations have contributed to the advancement of his research and the development of effective cancer therapies.

Conclusion

Seema Kantak's contributions to cancer treatment through his innovative patents and collaborations highlight his commitment to improving patient care. His work continues to influence the field of oncology and offers hope for better therapeutic options in the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…